TY - JOUR
T1 - Deep sequencing detects very-low-grade somatic mosaicism in the unaffected mother of siblings with nemaline myopathy
AU - Miyatake, Satoko
AU - Koshimizu, Eriko
AU - Hayashi, Yukiko K.
AU - Miya, Kazushi
AU - Shiina, Masaaki
AU - Nakashima, Mitsuko
AU - Tsurusaki, Yoshinori
AU - Miyake, Noriko
AU - Saitsu, Hirotomo
AU - Ogata, Kazuhiro
AU - Nishino, Ichizo
AU - Matsumoto, Naomichi
N1 - Funding Information:
We thank all the participants for their cooperation in this research. We also thank Ms. K. Takabe and Mr. T. Miyama, from the Department of Human Genetics, Yokohama City University Graduate School of Medicine, for their technical assistance. This work was supported by grants from the Ministry of Health, Labour and Welfare of Japan (N. Miyake, N. Matsumoto), a Grant-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Science (N. Matsumoto), a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (N. Miyake, H.S.), a Grant-in-Aid for Young Scientists (B) (E.K.), a research grant from the Yokohama Foundation for Advancement of Medical Science (S.M.), the Takeda Science Foundation (N. Miyake, H.S., N. Matsumoto), the Fund for the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems (N. Matsumoto), the Strategic Research Program for Brain Sciences (E.K., N. Matsumoto), a Grant-in-Aid for Scientific Research on Innovative Areas (Transcription Cycle) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (N. Miyake, N. Matsumoto), a Grant-in-Aid for Research on Intractable Diseases, Comprehensive Research on Disability, Health and Welfare (Y.K.H., I.N.), a Grant-in-Aid for Applying Health Technology (Y.K.H., I.N.) from the Ministry of Health, Labour and Welfare, Japan , and an Intramural Research Grant 23-5 for Neurological and Psychiatric Disorders of NCNP (I.N.).
PY - 2014/7
Y1 - 2014/7
N2 - When an expected mutation in a particular disease-causing gene is not identified in a suspected carrier, it is usually assumed to be due to germline mosaicism. We report here very-low-grade somatic mosaicism in ACTA1 in an unaffected mother of two siblings affected with a neonatal form of nemaline myopathy. The mosaicism was detected by deep resequencing using a next-generation sequencer. We identified a novel heterozygous mutation in ACTA1, c.448A>G (p.Thr150Ala), in the affected siblings. Three-dimensional structural modeling suggested that this mutation may affect polymerization and/or actin's interactions with other proteins. In this family, we expected autosomal dominant inheritance with either parent demonstrating germline or somatic mosaicism. Sanger sequencing identified no mutation. However, further deep resequencing of this mutation on a next-generation sequencer identified very-low-grade somatic mosaicism in the mother: 0.4%, 1.1%, and 8.3% in the saliva, blood leukocytes, and nails, respectively. Our study demonstrates the possibility of very-low-grade somatic mosaicism in suspected carriers, rather than germline mosaicism.
AB - When an expected mutation in a particular disease-causing gene is not identified in a suspected carrier, it is usually assumed to be due to germline mosaicism. We report here very-low-grade somatic mosaicism in ACTA1 in an unaffected mother of two siblings affected with a neonatal form of nemaline myopathy. The mosaicism was detected by deep resequencing using a next-generation sequencer. We identified a novel heterozygous mutation in ACTA1, c.448A>G (p.Thr150Ala), in the affected siblings. Three-dimensional structural modeling suggested that this mutation may affect polymerization and/or actin's interactions with other proteins. In this family, we expected autosomal dominant inheritance with either parent demonstrating germline or somatic mosaicism. Sanger sequencing identified no mutation. However, further deep resequencing of this mutation on a next-generation sequencer identified very-low-grade somatic mosaicism in the mother: 0.4%, 1.1%, and 8.3% in the saliva, blood leukocytes, and nails, respectively. Our study demonstrates the possibility of very-low-grade somatic mosaicism in suspected carriers, rather than germline mosaicism.
KW - ACTA1
KW - Deep resequencing
KW - Low-grade somatic mosaicism
KW - Nemaline myopathy
KW - Next-generation sequencer
UR - http://www.scopus.com/inward/record.url?scp=84901922264&partnerID=8YFLogxK
U2 - 10.1016/j.nmd.2014.04.002
DO - 10.1016/j.nmd.2014.04.002
M3 - 学術論文
C2 - 24852243
AN - SCOPUS:84901922264
SN - 0960-8966
VL - 24
SP - 642
EP - 647
JO - Neuromuscular Disorders
JF - Neuromuscular Disorders
IS - 7
ER -